Actively Recruiting
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
Led by Washington University School of Medicine · Updated on 2026-03-25
40
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to evaluate the feasibility and preliminary efficacy of an artificial intelligence (AI)-generated personalized question prompt list (a list of suggested questions to ask during outpatient appointments) for patients with hematologic cancers. The intervention will involve tailoring a standardized prompt to patients' individual characteristics and concerns. This prompt will then be used to ask Washington University's (WashU) HIPAA compliant ChatGPT to generate personalized question lists for outpatient appointments. Analyses will assess the impact of personalized QPLs on patients' question-asking behavior; communicative self-efficacy; and self-reported amount and satisfaction with information obtained about their disease and its treatment. Sub-analyses will explore patterns in questions generated by WashU ChatGPT. Patients will also provide feedback pertaining to the perceived helpfulness and ease-of-use of WashU-ChatGPT-generated question lists, as well as their attitudes and intentions regarding use of AI chatbots and whether they would engage in pre-appointment AI-assisted question brainstorming independently in the future.
CONDITIONS
Official Title
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with lymphoma (ICD-10 codes C81-C88) or multiple myeloma (ICD codes C90.0-C90.02)
- Scheduled follow-up appointment at a participating outpatient oncology clinic within the next month
- Receiving infusion or injection-based systemic therapy intended to cure or manage the disease at a frequency of once every 1-4 weeks
- Aged between 20 and 99 years at enrollment
- Able to independently consent to medical care without cognitive impairment
- No visual impairments or English literacy limitations interfering with study participation
- Able to use email and complete electronic informed consent
You will not qualify if you...
- Patients aged under 20 or over 99 years
- Documented cognitive impairment or need for legally authorized representative to consent
- Visual impairments or English literacy issues that prevent reading or communicating during appointments
- Unable to use email or complete electronic consent forms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
J
Jessica Hahne, MA, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here